August 1st, 2023– RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization
June 7th, 2023- RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product
May 22nd, 2023- RevBio Receives ISO Certification for its Quality Management Systems
February 14th, 2023- RevBio Receives a Strategic Investment from Pacific Dental Services to Support Ongoing Clinical Trials in Implant Dentistry
January 18th, 2023- RevBio Receives Approval to Start a Dental Clinical Trial in Italy for its Regenerative Biomaterial
2022
December 15th, 2022- A Lowell Biotech will test its ‘bone glue’ in space, Boston Business Journal Article
December 9th, 2022- RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station
November 15th, 2022- Novel Bone Adhesive to Fly on SpaceX CRS-26
September 20th, 2022- RevBio Receives NIH Grant to Explore the Treatment of Vertebral Compression Fractures with Its Regenerative Bone Adhesive Technology
September 15th, 2022 — RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial
2021
October 25th, 2021– BONEZONE: RevBio Looked Below the Ocean to Find a Way to Treat Bone Fractures
April 6th, 2021 — RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology
March 9th, 2021 — RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station
February 4th, 2021 — RevBio Enters the Animal Health Market to Help Improve Canine Dental Care
2020
August 4th, 2020 — LaunchPad Medical Rebrands as RevBio and Launches an Updated Website
July 7th, 2020 — LaunchPad Medical Initiates its First European Clinical Study
May 5th, 2020 — LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures
2019
December 19th, 2019 — LaunchPad Medical Accelerates Enrollment in its First-In-Man Clinical Study
November 6th, 2019 — LaunchPad Medical Wins NIH HEAL Grant to Reduce Opioid Use and Addiction
September 12th, 2019 — LaunchPad Medical Received FDA Approval to Initiate a Clinical Study